Literature DB >> 9798907

Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG.

S Goswami1, A Gupta, S K Sharma.   

Abstract

Human glioblastoma multiforme cell lines, brain tumor biopsy tissue, and normal human fetal brain synthesize interleukin (IL)-6 and IL-6 receptor (IL-6R). Neither of these is expressed in human neurons or neuroblastoma cell lines in culture. Astrocytes from fetal brain grown in culture retain the ability to synthesize IL-6 but do not express IL-6R as inferred from RT-PCR and Southern blot studies. Coexpression of IL-6 and IL-6R in the glioblastoma cell line U87MG is confirmed by immunofluorescence staining. Both specific monoclonal antibodies against IL-6 and IL-6R and antisense oligonucleotide to IL-6 mRNA inhibit the growth of U87MG cells in culture, suggesting the existence of a functional autocrine growth loop. Anti-IL-6 antibodies also inhibit the growth of glioblastoma cell lines U373 and U118. The expression of IL-6 by human fetal astrocytes in culture is highly suggestive of its role as an oncofetal protein responsible for rapid proliferation of fetal and tumor cells but not cells of adult brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9798907     DOI: 10.1046/j.1471-4159.1998.71051837.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  Using the neurotransmitter serotonin to target imaging agents to glioblastoma cells.

Authors:  Alexander Sturzu; Sumbla Sheikh; Uwe Klose; Hartmut Echner; Hubert Kalbacher; Martin Deeg; Thomas Nägele; Marius Horger; Ulrike Ernemann; Stefan Heckl
Journal:  Invest New Drugs       Date:  2012-12       Impact factor: 3.850

2.  IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines.

Authors:  Qinglin Liu; Gang Li; Ronghui Li; Jie Shen; Qiaowei He; Lin Deng; Cai Zhang; Jian Zhang
Journal:  J Neurooncol       Date:  2010-04-02       Impact factor: 4.130

3.  Microglia/macrophages promote glioma progression.

Authors:  Haiyan Zhai; Frank L Heppner; Stella E Tsirka
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

4.  Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse.

Authors:  Seung Wook Kim; Jang Seong Kim; John Papadopoulos; Hyun Jin Choi; Junqin He; Marva Maya; Robert R Langley; Dominic Fan; Isaiah J Fidler; Sun-Jin Kim
Journal:  Int Immunopharmacol       Date:  2011-01-18       Impact factor: 4.932

Review 5.  Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.

Authors:  R E Kast
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

6.  Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation.

Authors:  Jean-Jacques Dubost; Christine Rolhion; Andrei Tchirkov; Suzanne Bertrand; Jacques Chassagne; Annie Dosgilbert; Pierre Verrelle
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

7.  Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.

Authors:  Rui Pedro Galvão; Hui Zong
Journal:  Curr Pathobiol Rep       Date:  2013-03-01

8.  Glioblastoma in multiple sclerosis: a case report.

Authors:  Giovanni Frisullo; Agata Katia Patanella; Viviana Nociti; Alessandro Cianfoni; Raffaele Iorio; Assunta Bianco; Alessandro Marti; Pietro Attilio Tonali; Anna Paola Batocchi
Journal:  J Neurooncol       Date:  2009-02-13       Impact factor: 4.130

Review 9.  Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.

Authors:  Wei Zhou; Zheng Jiang; Xingang Li; Yangyang Xu; Zhenyu Shao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-09       Impact factor: 4.553

10.  Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors.

Authors:  Vassilis Samaras; Christina Piperi; Penelope Korkolopoulou; Athanasios Zisakis; Georgia Levidou; Marios S Themistocleous; Efstathios I Boviatsis; Damianos E Sakas; Robert W Lea; Anastasios Kalofoutis; Efstratios Patsouris
Journal:  Mol Cell Biochem       Date:  2007-06-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.